JP
Moleculin Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Annamycin (AnnAraC) | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Phase 3 |
| Annamycin | Soft Tissue Sarcoma Lung Metastases | Phase 1/2 |
| WP1066 | Recurrent Malignant Glioma / Glioblastoma | Phase 1 |
| WP1122 | Glioblastoma Multiforme | Preclinical/Phase 1 |
| WP1222 | Cutaneous T-Cell Lymphoma | Preclinical |
Leadership Team at Moleculin Biotech
WV
Walter V. Klemp
Founder, Chairman, President & CEO
DP
Donald Picker, PhD
Chief Scientific Officer (Part-time)
DJ
Dr. John Paul Waymack
Senior Chief Medical Officer
MD
Michael D. Cannon
Director
EC
Elizabeth Cermak
Director
JC
John Climaco
Director
WP
Waldemar Priebe, PhD
Founder, Chair of Scientific Advisory Board
DD
Daniel D. Von Hoff, MD
Member, Scientific Advisory Board